Mirus Bio LLC
545 Science Drive
Suite A
Madison
Wisconsin
53711
United States
Tel: 608-441-2852
Fax: 608-441-2849
Website: http://www.mirusbio.com/
30 articles about Mirus Bio LLC
-
Mirus Bio Receives ISO 13485:2016 Certification
1/31/2024
Mirus Bio today announced that its quality management system (QMS) has achieved ISO 13485:2016 certification.
-
Mirus Bio Launches RevIT™ AAV Enhancer
8/3/2023
Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical manufacturing, and research applications, announced the launch of the RevIT AAV Enhancer.
-
Mirus Bio Expands TransIT-VirusGEN® SELECT Portfolio with the Addition of Transfection Kits to Increase Titers in Cell and Gene Therapy Manufacturing
2/24/2022
Mirus Bio, a leading provider of delivery solutions within Gamma Biosciences , today launched Trans IT-VirusGEN ® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications.
-
Mirus Bio Introduces the VirusGEN® GMP Product Line for Large-scale Therapeutic Adeno-associated Virus and Lentivirus Production
8/11/2021
Mirus Bio, today announces the launch of the TransIT ® VirusGEN ® GMP product line.
-
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines
5/18/2021
-- Lipid-polymer nanocomplexes (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications -- Investment will support GMP launch of TransIT VirusGEN for high-productivity, cell-adaptive transfection in viral vector manufacturing -- Highly complementary engineering and delivery capabilities extend Gamma's advanced therapy offering
-
MiRus™ Announces First Clinical Use of the MiRus™ 3DR™ Printed Lumbar Interbody Fusion System
6/11/2020
MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.
-
MiRus™ Acquires 50,000 SQFT Manufacturing Facility
6/24/2019
This adds to MiRus' current 20,000 sqft manufacturing facility.
-
MiRus™ Wins Two 2018 Spine Technology Awards
9/17/2018
Winning Multiple Awards in One Year, MiRus Takes Honors for EUROPA™ Pedicle Screw System and GALILEO™ Spine Alignment Monitoring System.
-
Mirus Bio LLC Release: Introducing A Transient Transfection Platform That Produces High Protein Titers With Robust Cell Growth In Relevant CHO Cells
8/25/2015
-
Mirus Bio LLC Releases Video Illustration: "The Simplicity Of Transfection", Produced By Madison, WI Company, TruScribe
11/13/2014
-
Mirus Bio LLC New Product Packaging Fully Re-purposeful, Recyclable
3/12/2014
-
Mirus Transfectopedia™: Mirus Bio LLC Announces A New In-depth Transfection Resource Guide
2/6/2014
-
Mirus Bio LLC Release: Catch The “Buzz” With The NEW Transit®-Insect Transfection Reagent
12/11/2013
-
Mirus Bio LLC Announces Transfection Advance: TransIT-X2 Dynamic Delivery System
7/31/2013
-
Mirus Bio LLC Release: the First Dedicated Breast Cancer Cell Line Transfection Reagent
4/4/2013
-
Mirus Bio LLC Suit against Fugent Dismissed
1/17/2012
-
Mirus Bio LLC and Reinnervate Limited Collaborate to Introduce the 3D Transfection System: Enabling Transfection of Cells in 3D Culture
11/16/2011
-
Mirus Bio LLC to Award $250,000 of Transfection Products for Cutting Edge Research
7/12/2011
-
Mirus Bio LLC Release: Reagent Agent(SM) Transfection Cell Line Database from The Transfection Experts
3/8/2011
-
Mirus Bio LLC: Faster Biotherapeutic Protein Production With the New TransIT-PRO(TM) Transfection Kit
8/19/2010